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Abstract
The human liver fluke, Opisthorchis viverrini, infects millions of people throughout south-east Asia and is a major cause of
cholangiocarcinoma, or cancer of the bile ducts. The mechanisms by which chronic infection with O. viverrini results in
cholangiocarcinogenesis are multi-factorial, but one such mechanism is the secretion of parasite proteins with mitogenic
properties into the bile ducts, driving cell proliferation and creating a tumorigenic environment. Using a proteomic
approach, we identified a homologue of human granulin, a potent growth factor involved in cell proliferation and wound
healing, in the excretory/secretory (ES) products of the parasite. O. viverrini granulin, termed Ov-GRN-1, was expressed in
most parasite tissues, particularly the gut and tegument. Furthermore, Ov-GRN-1 was detected in situ on the surface of
biliary epithelial cells of hamsters experimentally infected with O. viverrini. Recombinant Ov-GRN-1 was expressed in E. coli
and refolded from inclusion bodies. Refolded protein stimulated proliferation of murine fibroblasts at nanomolar
concentrations, and proliferation was inhibited by the MAPK kinase inhibitor, U0126. Antibodies raised to recombinant Ov-
GRN-1 inhibited the ability of O. viverrini ES products to induce proliferation of murine fibroblasts and a human
cholangiocarcinoma cell line in vitro, indicating that Ov-GRN-1 is the major growth factor present in O. viverrini ES products.
This is the first report of a secreted growth factor from a parasitic worm that induces proliferation of host cells, and supports
a role for this fluke protein in establishment of a tumorigenic environment that may ultimately manifest as
cholangiocarcinoma.
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Introduction
Cholangiocarcinoma (CCA), or cancer of the bile ducts, is
prevalent in people from Thailand and Laos whose staple diet
includes uncooked fish which harbour the liver fluke, Opisthorchis
viverrini, the main risk factor for this cancer in the region [1]. There
is no stronger link between a parasite and cancer than that
between O. viverrini and CCA - indeed WHO data suggest that as
many as one-third of the nine million infected people will contract
cancer [2]. This is a striking figure compared to data from other
carcinogenic microbes, such as Helicobacter pylori, human papilloma
virus and the hepatitis viruses, where less than one percent of
infected individuals develop infection-related cancers [2,3].
For opisthorchiasis, in vivo studies in hamsters and in vitro
investigations have indicated that the fluke’s excretory/secretory
(ES) products, metabolic products excreted and secreted into the
external environment from the excretory openings and epithelial
surface (tegument), include mitogens that likely play a role in the
initiation of CCA in infected humans and experimentally infected
hamsters [4,5]. To gain a better understanding of the host-parasite
interactions underlying the molecular pathogenesis of opisthor-
chiasis, we screened both the transcriptome [6] and the ES
proteome (J. Mulvenna et al., unpublished) of the fluke for genes
encoding proteins with ontologies that were associated with
human cancers. A homologue of human granulin, a secreted
growth factor implicated in many aggressive and invasive cancers,
was identified.
The granulin domain consists of 12 highly conserved cysteines
and is found in diverse phyla from eubacteria to humans, and
subsequently has many synonyms [7]. Compounding the confu-
sion, the term granulin can also refer to the small 6–10 kDa
granulin domain (also named epithelins or GEM:granulin/
epithelin modules) found in the majority of animals, or the
vertebrate protein, progranulin (PGRN), which in mammals is a
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granulin motifs [8]. PGRN protein is also known as PC cell-
derived growth factor (PCDGF), proepithelin (PEPI), Granulin/
epithelin precursor (GEP), GP88, acrogranin, granulin or epithelin
precursor [9]. Herein we will refer to the large multihomodomain
form from vertebrates as PGRN, and granulin (GRN) will refer to
the individual granulin domains.
There is a broad distribution of PGRN in human organs and
tissues, and elevated levels of mRNA are found in organs with
neuronal cells (cerebellum), hematopoietic stem cells (spleen) and
rapidly dividing epithelium (skin, gastrointestinal tract and
wounded epithelia) [10,11]. Numerous functions for GRNs have
been reported but the roles in cell cycle control and wound healing
are noteworthy [8]. Numerous mutations have been observed
within the human PGRN gene with many linked to psychiatric
disorders including Alzheimer’s disease and frontotemporal
dementia [12,13].
Over-expression of PGRN is linked to tumorigenesis in
numerous human tissues, including liver cancers, and is associated
with an aggressive and invasive tumour phenotype [14,15]. GRN
is a potent proliferative agent but has other pro-tumor qualities
that are not yet well characterized. It may promote carcinoma
progression by promoting angiogenesis, insensitivity to apoptosis,
promotion of tumor invasion and anchorage independence which
all support tumor expansion in the unfavorable interstitial
environment [7,16,17]. Preventing over-expression of PGRN in
a range of tumor types, either through gene silencing or
neutralizing antibodies, reduces or entirely inhibits tumor
progression [18]. Over-expression of PGRN is an indicator of
poor prognosis for a range of cancer types, and anti-GRN
antibodies have been successfully employed in mice as therapy for
hepatocellularcarcinoma (HCC) [19].
Large-scale gene sequencing efforts have revealed GRN
homologues in the majority of parasitic phyla [20,21,22]. Like
free-living eukaryotes, parasitic helminths probably utilize GRN to
regulate growth and development of their own cells. By contrast,
here we describe the detection of GRN in the ES products of O.
viverrini and its binding to mammalian biliary epithelial cells in situ.
Furthermore, recombinant O. viverrini GRN stimulated prolifera-
tion of fibroblasts, whereas antibodies against the recombinant
GRN inhibited the ability of ES products to promote proliferation.
Together these findings support a role for this fluke protein in
establishment of a tumorigenic environment that may ultimately
manifest as CCA.
Results
Ov-GRN-1 is a homologue of a human growth factor
associated with cancer progression
Characterization of the protein profile of O. viverrini adult worm
ES products using LC-MS/MS revealed a 19 amino acid peptide,
with a MOWSE score of 50 (delta error -0.0464) (Figure 1 inset),
that matched to a single contig encoding a protein with sequence
similarity to human granulin (not shown). The cDNA was termed
Ov-grn-1 and its protein product Ov-GRN-1; the sequences were
submitted to GenBank under accession number FJ436341.
Verification of the MS/MS identification was then performed
using multiple-reaction monitoring (MRM) transitions targeted
against the peptide identified in the shotgun proteomics. Firstly, a
tryptic digest of O. viverrini ES products, collected after one day of
culture, was analyzed and the target peptide identified and
fragmented. Next, recombinant Ov-GRN-1 in water was digested
and analyzed in the same fashion. The target peptide from the ES
sample was identified at the same elution time and with an
identical product ion spectrum as that generated for recombinant
Ov-GRN-1 (Figure 1). The peptide observed showed very
abundant y-ion fragments, as expected, on the C-terminal side
of the peptide. The peptide also revealed a missed trypsin cleavage
at the Arg residue, due to the Pro residue on its C-terminal side.
The combination of the initial MS/MS data, elution time of the
target peptide in both samples and the similarity of MRM
fragmentation patterns strongly supports the presence of Ov-GRN-
1 in the ES products of O. viverrini.
Ov-GRN-1, like homologues from the related liver fluke
Clonorchis sinensis and earthworms, has an N-terminal signal
peptide followed by a single GRN core domain. Most other
proteins containing a GRN domain consist of multiple GRN
domains (PGRN) or at least one GRN domain fused to other
domains including proteases, protease inhibitors and fibronectin
(Figure 2A). Ov-GRN-1 consists of a predicted secretion signal
peptide followed by an 84 amino acid GRN domain of 9.04 kDa
with twelve conserved cysteines. Whereas no N-linked glycosyla-
tion sites were predicted, four putative O-glycosylation sites were
identified at Ser-26, Thr-35, Thr-41 and Ser-61. The core GRN
domain of Ov-GRN-1 shared 43.6% identity at the amino acid
level with granulin F, the closest human homologue, and 85%
identity with an EST from the related liver fluke, Clonorchis sinensis
(Figure 2B). Data from the few GRN structures available suggest
that Ov-GRN-1 adopts the general GRN fold and disulphide
bonding pattern akin to carp GRN, the only complete GRN
structure available to date [23]. The NMR derived structure of
carp (Cyprinus carpio) granulin [23] was used as the template on
which to build a molecular model of Ov-GRN-1 (Figure 2C). The
two proteins shared 32% identity over their granulin core
domains. The lowest energy structure from 50 calculated using
MODELLER was selected as an approximation of the structure of
Ov-GRN-1. The model contained no violations of distance
restraints and the Ramachandran plot, calculated with PRO-
CHECK-NMR [24], showed a single residue in the disallowed
regions.
Phylogenetic relationships
Ov-GRN-1 grouped very closely with its orthologue from the
related liver fluke, C. sinensis, a parasite that has also been
implicated as a cause of human CCA [25], and this clade obtained
Author Summary
The oriental liver fluke is endemic through South-East Asia
and is the major cause of cause of liver cancer in north-
eastern Thailand. The molecules that are secreted by the
parasite cause cells to multiply quicker than they normally
would, and excessive cell growth is a key stage in the
initiation of many cancers. We identified a secreted protein
from the fluke, termed granulin, which has a similar
structure to a human growth factor associated with many
aggressive cancers. Granulin is secreted by the parasite
into the bile ducts where it causes host cells to proliferate.
The proliferative activity of fluke secreted proteins was
blocked by antibodies against granulin, indicating that it is
the major cell growth-inducing molecule released by the
parasite. Identifying the function of granulin will enable us
to understand how and why this debilitating yet neglected
pathogen causes cancer in so many people in South-East
Asia. This and future work will contribute towards the
development of new strategies to reduce both parasite
prevalence and the incidence of the most fatal of liver
cancers in Thailand.
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Trichoplax, slime mould, the free-living nematode Caenorhabditis
elegans and human granulin B also formed a clade with the liver
fluke GRNs, although this did not obtain bootstrap support of
greater than 50%. Interestingly, the blood fluke (Schistosoma) GRNs
did not group closely with Ov-GRN-1 – most O. viverrini genes
share greater sequence identity with other platyhelminth genes [6]
than they do with genes from other phyla, suggesting that the
phylogeny presented here reflects functional protein relationships
rather than taxonomic relationships. It is also noteworthy that the
schistosome GRN domains were probably derived from a multi-
domain PGRN.
Ov-grn-1 is expressed throughout development of the
liver fluke
Reverse transcription PCR using RNA from different Opisthor-
chis life cycle stages amplified a product of the expected size,
,300 bp, in all developmental stages tested (Figure S1), indicating
that Ov-grn-1 was constitutively expressed throughout the devel-
opmental cycle of the liver fluke. An amplicon was not detected in
the absence of reverse transcriptase enzyme (not shown),
confirming the absence of contaminating genomic DNA. The
constitutively expressed actin gene served as a control and was
expressed in all stages.
Expression of recombinant Ov-GRN-1
Ov-GRN-1 was expressed in E. coli and in Sf9 insect cells. We
herein refer to the E. coli-derived recombinant protein as Ov-GRN-
1e and Sf9-derived protein as Ov-GRN-1s. Soluble 66His tagged
Ov-GRN-1s protein with a molecular mass of ,14 kDa was
expressed in Sf9 cells at a yield of #200 mg purified protein per
litre of culture medium. A combination of cation exchange and
Ni-NTA affinity chromatographies followed by a second Ni-NTA
purification resulted in recombinant granulin that appeared to be
greater than 95% pure based on SDS-PAGE gels (not shown). Ov-
GRN-1e was highly expressed (up to 60 mg/L) in each of three E.
coli cell lines (BL21, Rosetta, Rosetta-gami) but in each case the
Ov-GRN-1e was insoluble and required urea (or other chaotropic
agents) to solubilise. Different induction times and temperatures
were assessed, and none of these variables promoted the solubility
Figure 1. Comparison of multiple-reaction monitoring (MRM) MS/MS fragmentation spectra targeted against a 19 amino acid
Ov-GRN-1 peptide identified during the course of shotgun proteomics. Recombinant Ov-GRN-1 (red) and O. viverrini ES products (blue) were
analyzed in separate MRM experiments targeted against a previously identified Ov-GRN-1 peptide. In both experiments the target precursor ion
eluted from the reverse-phase column at the same time and produced identical MS/MS fragmentation patterns. The MS/MS spectrum from the
original identification is shown in the inset and the identified fragments are labeled. Peaks corresponding to the MS/MS spectra are highlighted with
an asterisk on the MRM fragmentation spectrum along with the triple charged precursor ions.
doi:10.1371/journal.ppat.1000611.g001
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PLoS Pathogens | www.plospathogens.org 3 October 2009 | Volume 5 | Issue 10 | e1000611Figure 2. Ov-GRN-1 is a secreted growth factor belonging to the granulin family. Panel A - structural architecture of proteins containing
granulin domains. Grn or GrnA-G: granulin domains, Inhib: cathepsin propeptide inhibitor, FN: Fibronectin type III, Sig: Secretion Signal sequence,
Protease: Papain family cysteine protease, Esterase: SGNH hydrolase type esterase. Sequence accession numbers are as described in the legend for
Figure 2, with structural architecture obtained from Interpro 18.0 database. Panel B - multiple sequence alignment of Ov-GRN-1 and granulin domains
from other organisms. Identical amino acids are in black boxes and similar amino acids are in gray boxes. The granulin core domain is highlighted by
a pink box. Theoretical disulphide bonds are numbered one to six above each cysteine residue. GenBank accession numbers are as follows:
Opisthorchis viverrini Ov-GRN-1- FJ436341*; Clonorchis sinensis (parasitic liver fluke) - AT006891*; Schistosoma japonicum (parasitic blood fluke) -
AY810079*; Caenorhabditis elegans (free living roundworm) - NP_492982*; Homo sapiens (human) granulin domains A and B - AW51601; Mus
musculus (mouse) - NM_008175*. *Amino acid numbering is from the initiator (or predicted initiator) methionine. Panel C - molecular model of the
granulin core domain of Ov-GRN-1 based on the nuclear magnetic resonance structure of carp granulin [23] and an overlay where Ov-GRN-1 is
superimposed on carp granulin. Disulphide bonds are highlighted in yellow.
doi:10.1371/journal.ppat.1000611.g002
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nant protein, BL21 E. coli cells transformed with pET41a encoding
the Ov-GRN-1 ORF were grown at 37uC and induced for 16 h.
Recombinant protein was purified on Ni-NTA resin under
denaturing conditions to yield .95% pure protein (Figure 4A).
Refolding of the purified denatured protein was undertaken, and
the best conditions identified yielded ,15% recovery of soluble
protein by refolding in 20 mM Tris pH 7.5, 1 mM CaCl2 for
24 hr.
Antibodies against Ov-GRN-1 recognize native epitopes
IgG antibodies raised against recombinant Ov-GRN-1e and
GRN-1s proteins in mice were employed to probe the recombi-
nant immunogens and Opisthorchis somatic adult extract (SAE) by
Western blotting under both native and denaturing/reducing
conditions. Bands were only visible when SAE was probed under
native conditions with both anti-GRN-1s and anti-GRN-1e IgGs,
with a strong band visible at 38 kDa, higher than the predicted
9 kDa mass of the monomeric protein (Figure 4B). Neither
antibody bound to any proteins under reducing/denaturing
conditions (not shown), suggesting that conformational epitopes
were the target of anti-GRN-1 antibodies, and that the native
protein might form homo-multimers or form complexes with other
proteins under native conditions. Control antibodies did not
produce any bands under native or denaturing/reducing condi-
tions. Anti-GRN-1s IgG was used to localize the sites of expression
Figure 3. Neighbor joining phylogenetic tree for the granulin core domains from a range of phyla. Numbers on the branches are
bootstrap values that obtained greater than 50% support from 1000 replicates. GenBank accession numbers are as follows: Ov-GRN-1 - FJ436341;
Cs- Clonorchis sinensis (parasitic liver fluke) AT006891, Sj - Schistosoma japonicum (parasitic blood fluke) AAX25968; Mx - Myxococcus xanthus
(bacterium) Q1CVL1; Nc - Neurospora crassa (fungus) Q7S2H4; Dr - Danio rerio (zebrafish) A8E5C4; Xt - Xenopus tropicalis (frogs) CAJ82256; Nv -
Nematostella vectensis (sea anemone) A7SM19; Aa - Aedes albopictus (mosquito) B0FU00; Os - Oryza sativa (rice) Q7XR52; Eg - Elaeis guineensis var.
tenera (oil palm) A6N8F8; Ta - Trichoplax adhaerens (tablet animals) B3RQV7; Dd - Dictyostelium discoideum (amoeba) Q54QR7; At - Arabidopsis
thaliana (mouse-ear cress) Q9LT78; Ce - Caenorhabditis elegans (free living roundworm) BAE35565; Hs - Homo sapiens (human) EAW51601; Mm - Mus
musculus (mouse) NP_492982.
doi:10.1371/journal.ppat.1000611.g003
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PLoS Pathogens | www.plospathogens.org 5 October 2009 | Volume 5 | Issue 10 | e1000611Figure 4. Recombinant Ov-GRN-1e expressed in E. coli and verification of anti-Ov-GRN-1 antibodies. Panel A: 15% SDS PAGE gel stained
with Imperial Blue showing purification of Ov-GRN-1e. Lane 1: Benchmark Marker (Invitrogen), 2: French pressed total cell pellet, 3: Insoluble fraction,
4: column eluate containing purified recombinant Ov-GRN-1e, 5: refolded Ov-GRN-1e. Panel B: Recognition of native Ov-GRN-1 in O. viverrini somatic
protein extract by mouse anti-Ov-GRN-1s IgG. SDS-PAGE was conducted under native conditions and the blot was probed with control IgG (1) or anti-
Ov-GRN-1s IgG (2). The arrow highlights the major band at 38 kDa. Molecular masses (kDa) are indicated on the right. Panel C: Immunolocalization of
Ov-GRN-1 in histological sections of adult O. viverrini in the bile ducts of experimentally infected hamsters. The left panel was probed with control
IgG; the right panel was probed with anti-Ov-GRN-1e IgG. The bottom panel shows a liver section from an uninfected hamster that was probed with
anti-Ov-GRN-1e IgG. Peroxidase staining is revealed as a brown/rust colored deposit in panel B and Mayer’s Haematoxylin counterstained the nuclei in
blue. Red arrows highlight the regions within in the O. viverrini parasite and bile duct tissue that stained positive for Ov-GRN-1.
doi:10.1371/journal.ppat.1000611.g004
Liver Fluke Granulin Promotes Host Cell Growth
PLoS Pathogens | www.plospathogens.org 6 October 2009 | Volume 5 | Issue 10 | e1000611within adult O. viverrini and in the surrounding bile ducts of an
experimentally infected hamster. Ov-GRN-1 exhibited ubiquitous
expression through all tissues, particularly in the gut, tegument
and tegument extrusions of the adult worm (Figure 4C, right upper
panel). Interestingly, the protein was also strongly detected in the
bile duct epithelial cells in close proximity to the liver fluke.
Control mouse IgG did not bind to any tissue or structures in the
fluke or hamster tissues (Figure 4C, left panel). Additionally anti-
Ov-GRN-1s IgG showed no affinity for host granulin as indicated
by a lack of staining in uninfected hamster liver (Figure 4C, lower
right panel)
O. viverrini ES products and recombinant Ov-GRN-1e
induce cell proliferation
Others have shown that O. viverrini causes proliferation of
fibroblasts and the KKU-100 CCA cell line when these cells are
co-cultured in the presence of live adult O. viverrini in a non-contact
format [4,26]. We reproduced these findings (Figures 5A and S2A)
and proceeded to show that soluble ES products from O. viverrini
stimulated proliferation of NIH-3T3 fibroblasts (Figures 5B, S2B
and S3) and the KKU-100 CCA line (not shown). Cell
proliferation was measured using two distinct approaches. WST-
1 is a measure of metabolic activity of cells, and although it is
routinely used to measure cell growth over time, metabolic
variations in cells exposed to different conditions (e.g. in the
presence of ES products) can mask changes in real cell numbers.
We also assessed the growth of cells using a real time index of
measurement to corroborate the proliferation quantified by the
WST-1 assay using an xCELLigence system. The cell index
readout is a real time measure of conductivity which is indicative
of cell surface area in contact with the gold electrodes covering the
plate surface [27]. We optimised the conditions for ES-induced
cell growth to permit a thorough assessment of the effects of ES
products (and other treatments) over time. Cells were seeded at an
adequate density to determine growth over 3 days in a reliable
manner before reaching confluence. Conditions that resulted in a
minimum of two-fold growth of NIH-3T3 fibroblasts between
samples treated with and without ES over 3 days were determined
in the presence of increasing concentrations of bovine calf serum
(BCS) in a 96 well plate – final conditions were 0% BCS seeded at
6000 cells/well, 2% BCS at 2000 cells/well, 5% BCS at 700 cells/
well and 10% BCS at 300 cells/well. The optimal conditions
identified for detection of approximately two-fold proliferation of
NIH-3T3 fibroblasts induced by addition of ES compared with an
equal volume of PBS (control) were as follows: 2,000 cells seeded
per well and cultured for 3–8 h in DMEM containing antibiotic/
antimycotic at 37uC in 95% air/5% CO2 and 2% BCS prior to
addition of ES products (20 ml) to a final concentration of 20 mg/
ml. Cells were cultured in the presence of ES or PBS and cell
numbers were determined using the WST-1 dye procedure.
Addition of ES to cells grown in all serum concentrations tested
resulted in changes in cell growth and morphology; Figure 5C
presents the results of cell growth in the presence of 2% BCS. The
flattened fibroblastic shape of 3T3 cells changed upon addition of
ES products, resulting in a longer, narrower and more refractive
spindle shaped cell morphology.
A range of concentrations of recombinant Ov-GRN-1e was
included with cells under different culturing conditions, based on
information from other investigations with ES, as described above.
Nanomolar concentrations (50–200 nM) of Ov-GRN-1e induced
significant growth of cells above growth of control cells treated
with either PBS or an irrelevant recombinant protein purified
under the same conditions as for Ov-GRN-1e (Figures 6 and S4).
Four hundred nM Ov-GRN-1e induced significant growth after
one day (P,0.05), after which cell growth slowed and cell numbers
were equivalent to cells treated with control protein by day 3
(Figure 6A). At higher concentrations ($800 nM) the cells suffered
adverse effects and did not survive beyond 24 hr (not shown).
Compared to control protein, 200 nM Ov-GRN-1e promoted
significant growth after one day (P,0.05) and 50–200 nM Ov-
GRN-1e caused significant growth by day 3 (P,0.05; Figure 6B).
Cell proliferation induced by both ES products and recombinant
Ov-GRN-1 was completely ablated in the presence of 10 mM
U0126, an inhibitor of Erk1/2 signalling, indicating that Ov-GRN-
1, like human PGRN, signals via the MAPK pathway.
Intriguingly, refolded Ov-GRN-1e that was concentrated
(retentate) using a 3 kDa cut-off centrifugal concentrator mem-
brane did not induce cell growth, however the column flow
through (i.e. .3 kDa) did induce proliferation. Indeed, the
proliferation was greatly enhanced at lower concentrations
(10 nM) compared with refolded Ov-GRN-1e that had not
undergone concentration (50–200 nM; measured in real time by
xCELLigence - Figures 7 and S5). Using both SDS PAGE and
Western blotting with anti-66His antibody we identified a small
amount (,5–10% of purified and refolded protein) of refolded
protein that reproducibly passed through a 3 kDa cut-off
membrane.
Anti-Ov-GRN-1 antibodies block cell proliferation induced
by O. viverrini ES products
To determine whether Ov-GRN-1 was responsible for the
mitogenic activity of ES, we attempted to neutralize the mitogenic
activity of ES with anti-Ov-GRN-1 antibodies. Anti-GRN-1s IgG
inhibited ES-induced proliferation of NIH-3T3 fibroblasts
(Figures 8A and S6A). After 3 days of cell culture, significant
inhibition of proliferation was evident at concentrations of 20 and
40 mg/ml IgG in both 2% and 5% BCS cultures (P,0.01 -
,0.001). Similar antibody-induced suppression of proliferation
was obtained in the absence of BCS over two days (not shown), but
after two days control cells (treated with PBS) began to die.
NIH-3T3 cells were grown under identical conditions as
described above 220 mg/ml ES, 20 mg/ml test or control IgGs
and 2% BCS over 3 days - and monitored with the xCELLigence
system (Figures 8B and S6B). Cells treated with ES alone or ES in
the presence of control IgG grew at the same rate (F(2,186) P=0.65)
with a steady increase of 0.2–0.25 units over 24 hours and then a
reduced rate of increase of 0.05–0.1 units for the subsequent two
days. This was similar to the growth rates measured with WST-1.
When ES in the presence of either anti-Ov-GRN-1e or anti-Ov-
GRN-1s IgGs were incubated with cells, growth slowed signifi-
cantly (F(2,186) P,0.0001) compared to cells treated with ES alone
or ES plus control IgG and showed only minor variations from the
growth profile of NIH-3T3 cells treated with PBS alone
(Figure 8B).
The inhibitory effect of anti-Ov-GRN-1 IgG on the growth of
the KKU100 CCA cell line induced by ES products was also
assessed. Cells were cultured for 3 days in RPMI 1640/2% BCS
with a final concentration of 20 mg/ml ES. Cell growth is
presented as absorbance at 450 nm rather than as a growth ratio
because of the differences in growth characteristics between this
cell line and NIH-3T3 fibroblasts. The same general trend was
observed, whereby anti-GRN-1e and to a lesser but still significant
extent, anti-GRN-1s, IgGs inhibited proliferation induced by ES
in an antibody dose-dependent fashion (Figure 8C). Significant
inhibition was observed with 16 mg/ml (P,0.05) and 24 mg/ml
(P,0.001) anti-GRN-1e IgG. Addition of IgGs to cells in the
absence of ES had no effect on cell growth (not shown).
Liver Fluke Granulin Promotes Host Cell Growth
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Initiation of CCA in chronic opisthorchiasis in humans [28] and
experimentally infected hamsters [29] is thought to be multi-
factorial, involving (1) infection-induced inflammation, particularly
the release of reactive oxygen and nitrogen species from
inflammatory cells, (2) dietary nitrosamines consumed by endemic
populations, (3) secretion by the fluke of mitogens into the biliary
tree [5]. Co-culture of O. viverrini adult worms with mouse
fibroblasts (NIH-3T3) where parasites and cells are separated by a
porous membrane results in cell proliferation [4]. Here we show
that soluble ES products, in the absence of live O. viverrini parasites,
Figure 5. Proliferation of host cells in response to O. viverrini proteins. Panel A: Non-contact co-culture of 3 or 10 living adult O. viverrini
worms with KKU100 human biliary cancer cell line over time. Growth is expressed as a ratio of cells cultured in the presence or absence of O. viverrini.
Cell numbers were manually counted using a hemocytometer. Panel B: Effect of different concentrations of O. viverrini adult worm ES on the growth
of NIH-3T3 mouse fibroblasts over time. Cell growth was measured using WST-1 metabolic assay as a marker of mitochondrial enzyme activity.
Growth is expressed as a ratio compared to cells that did not receive ES with error bars indicating one standard deviation. Panel C: Morphology
changes of NIH-3T3 mouse fibroblasts cultured in the presence or absence of O. viverrini adult worm ES (20 mg/ml) after 3 days.
doi:10.1371/journal.ppat.1000611.g005
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fibroblasts and a human CCA cell line, and that proliferation
caused by ES products can be blocked with anti- Ov-GRN-1e
antibodies. This data implies that Ov-GRN-1 is perhaps the major
mitogenic factor in ES, and this protein contributes to the
development of an environment that is conducive to CCA.
The GRN protein family is found in a diverse range of organisms
including bacteria, plants and animals. Our phylogenetic analysis of
the protein family suggested that a majority of GRN proteins do not
form clades based on taxonomic groupings but rather group
according to protein functions. The individual GRN domains from
human PGRN form distinct clades with homologues from other
species, supporting the notion that these proteins have evolved to
perform distinct functions in different organisms, and furthermore,
individual GRN domains released after processing of the multi-
domain PGRN have also evolved to perform discrete functions. A
range of organisational archetypes are seen within the family, ranging
from single GRN domains behind a secretory signal peptide, as seen
in earthworms and the liver flukes, to multi-homodomain PGRNs
and even single GRN domains fused to other protein domains [7].
The structure of GRN is unique, although it can be partially
superimposed on the 3-dimensional fold of epidermal growth
factor (EGF), despite the absence of primary sequence identity
[30]. Furthermore, Ov-GRN-1 and human PGRN, like EGF,
triggers similar signalling cascades, including the MAPK pathway
[31]. When NIH-3T3 fibroblasts were co-cultured with O. viverrini
adult worms without serum, only mRNAs associated with EGF
and TGF-beta signalling pathways were significantly upregulated,
further supporting a role for Ov-GRN-1 in parasite-induced
proliferation and downstream signalling of host cells [32].
Granulin-induced cell proliferation can result in upregulation of
EGF family members, such as VEGF, which could account for
upregulation of genes involved in the EGF pathway [31].
Ov-GRN-1 was expressed at very low levels in lepidopteran (Sf9)
cells, limiting more thorough investigation of this form of the
protein. By contrast, Ov-GRN-1 was expressed at high yield in E.
coli and could be refolded into an active form that induced
proliferation at nanomolar concentrations. This is the first report,
to our knowledge, of a secreted growth factor from a parasite that
induces proliferation of host cells. This is also the first report of
functional recombinant expression of a single domain granulin.
Tolkatchev expressed all 7 granulin domains individually from
human PGRN but only three, granulins A, C and F, appeared to
adopt at least partially correct fold and induced growth [33].
Figure 6. Recombinant refolded Ov-GRN-1e stimulates growth of NIH-3T3 fibroblasts at nanomolar concentrations as measured by
WST-1 cell count assay. Growth is expressed as a ratio of cell numbers after incubation with recombinant proteins compared to PBS (growth
rate=1.0). Panel A: The effects of Ov-GRN-1e and control protein on NIH 3T3 cells for 3 days. To facilitate view of error bars, data points were offset by
0.05 units. Panel B: Growth of cells after three days of culture in the presence of 2–400 nM Ov-GRN-1e and Sm-TSP-2 control protein. All curves are the
averages of duplicates and standard deviations are shown as error bars at each data point. Asterisks denote significance at the P,0.05 (*), P,0.01 (**)
and P,0.001 (***) levels between growth ratios of cells cultured with Ov-GRN-1e and negative control protein at equivalent concentrations.
doi:10.1371/journal.ppat.1000611.g006
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recombinant protein that induced cell proliferation, the majority
of functional recombinant protein passed through a 3 kDa cut-off
membrane. If Ov-GRN-1 does indeed adopt a similar fold to carp
granulin (Figure 2C), the super helical structure held tightly
together by 6 disulphide bonds might well pass through a 3 kDa
membrane (Figure 7). Furthermore, the apparent molecular
weights of native human granulins purified from leukocytes range
from 1.7–3.2 kDa and would likely pass through a 3 kDa
membrane, as we observed here with functionally active Ov-
GRN-1 [34]. The low nanomolar activity displayed by refolded
Ov-GRN-1 is comparable to the activity of purified human
granulins [15].
GRN is associated with many aggressive cancers. It is over-
expressed in human liver [14,19], renal [35], breast [31,36,37],
bladder [16] and brain [15] tumors. It may promote cancer
progression by stimulating angiogenesis, suppressing anoikis (a
form of apoptosis), promotion of tumor invasion and anchorage
independence, all of which support tumor expansion in the
unfavourable interstitial environment [7,16,17]. Preventing the
activity of PGRN in a range of tumor types, either through gene
silencing or antibody neutralization, reduces or entirely inhibits
tumor progression [18]. Transfection of fibroblasts with PGRN
induces serum independent proliferation but does not transform
them into neoplastic cells, suggesting that the protein is probably
not oncogenic by itself, but over-expression of PGRN in the SW-
13 non-malignant adrenal carcinoma cell line made it highly
tumorigenic [38]. Indeed, PGRN is a therapeutic target for liver
cancer, particularly HCC. An anti-PGRN monoclonal antibody
inhibited tumor growth in vivo in nude mice transplanted with
human HCC [19]. The anti-PGRN antibody also inhibited
growth of hepatoma cells but had no significant effect on normal
liver cells, and inhibited the growth and proliferation of established
tumors via the p44/42 MAPK and Akt pathways. These findings
demonstrate that GRN is an important factor in the initiation of
liver cancer and the migration of cancerous cells. We showed here
that Ov-GRN-1 signals via the MAPK pathway, further accentu-
ating the potential role of this parasite protein in the initiation of
CCA in people with chronic opisthorchiasis.
Increased PGRN expression has not been reported in CCA,
however, when gene expression profiles from intrahepatic CCA
associated with or without O. viverrini were compared, genes
associated with growth factor signalling were the most highly
upregulated ontology in the non-fluke associated CCA, whereas
genes involved in xenobiotic metabolism were the most highly
upregulated genes in fluke associated CCA [39]. It is intriguing
that genes involved in growth factor signalling pathways were
selectively upregulated in non-fluke associated CCA. This prompts
the speculation that Ov-GRN-1 causes excessive proliferation and
migration of pre-cancerous and cancerous cells in the bile ducts of
infected people, obviating the necessity for local upregulation of
the host growth factors and associated signalling molecules during
tumorigenesis.
Why O. viverrini secretes such a potent growth factor that acts on
host cells is unclear. One potential role for fluke GRN is in the
wound repair. Inflammatory cells secrete peptides derived from
PGRN [34], and PGRN mRNA is highly induced in dermal
fibroblasts and epithelial cells following transcutaneous puncture
wounds [8]. Furthermore, recombinant PGRN increased the
accumulation of inflammatory cells, blood vessels and fibroblasts
at puncture sites, implying a direct role as a wound-healing growth
factor [9]. O. viverrini adult worms grasp the bile duct wall with
their suckers and feed on the biliary cells, often severely damaging
the epithelium. Additional inflammation occurs as a result of the
Figure 7. Refolded recombinant Ov-GRN-1e stimulates growth of NIH-3T3 fibroblasts at nanomolar concentrations as measured in
real time using an xCELLigence system (Roche). The curves represent the difference between control cells grown in medium plus PBS versus
test cells (recombinant proteins added) as measured by Cell Index; data have been normalized prior to sample addition. The control protein and
Ov-GRN-1e were added to cells at equimolar quantities, as previously determined and optimized using the WST-1 assay. Ov-GRN-1e before and after
(column flow-through) filtration through a 3 kDa cut-off nanosep filter are shown.
doi:10.1371/journal.ppat.1000611.g007
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GRN-1 might therefore play a role in wound repair at and around
the feeding site to minimize the pathology that the parasite causes
to the host. Another potential role for Ov-GRN-1 is in the
‘‘farming’’ of host cells for nutritional purposes. By promoting
growth of cells at the feeding site, the parasite is ensured of a
steady supply of nutrients. Blood-feeding leeches secrete a GRN
that inhibits thrombin activity [40], and Ov-GRN-1 might also
perform a similar function to interfere with clot formation while
feeding.
Like some other O. viverrini proteins, Ov-GRN-1 was identified
on the surface of and inside host biliary epithelial cells. O. viverrini
ES products adhere to and are internalised by hamster biliary
epithelial cells in the first order bile ducts as well as the small extra-
Figure 8. Inhibition of ES-induced cell proliferation by anti-Ov-GRN-1 IgG. Panel A: Anti-Ov-GRN-1s IgG inhibited growth in a dose-
dependent manner of NIH-3T3 fibroblasts induced by O. viverrini ES products as measured by the WST-1 metabolic assay. Panel B: Anti-Ov-GRN-1e
and anti-Ov-GRN-1s IgGs inhibited growth of NIH-3T3 fibroblasts induced by O. viverrini ES as measured in real time using an xCELLigence system
(Roche). Panel C: Anti-Ov-GRN-1e and anti-Ov-GRN-1s IgGs inhibited growth of KKU-100 cholangiocarcinoma cells induced by O. viverrini ES in a dose-
dependent manner. Data were obtained using the WST-1 metabolic assay. All data shown are means of triplicate experiments and standard
deviations at each data point are shown as error bars. Asterisks denote significance at the P,0.05 (*), P,0.01 (**) and P,0.001 (***) levels between
growth ratios or absorbance readings of cells cultured with anti-Ov-GRN-1 and negative control antibodies at equivalent bovine calf serum
concentrations.
doi:10.1371/journal.ppat.1000611.g008
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Until now, only one ES product that is internalized by host cells
had been identified - thioredoxin peroxidase [42]. The mechanism
of uptake of O. viverrini ES components by host cells is unknown.
With a related fluke, Schistosoma japonicum, fluke glutathione
transferase (GST) is translocated from the medium into a variety
of mammalian cell types via an endocytotic pathway involving
clathrin-coated pits [43]. Like most helminth parasites, O. viverrini
secretes a GST (J. Mulvenna et al., unpublished), which along
with other ES proteins (such as Ov-GRN-1), might enter host
cells via a similar endocytotic mechanism. Translocation of O.
viverrini proteins into host biliary epithelial cells is particularly
important due to the carcinogenic nature of this parasite and
the putative roles that internalised ES play in transforming
host cells [5]. Helicobacter pylori delivers the CagA protein into
gastric epithelial cells where it interacts with a kinase involved in
cell polarity, resulting in disorganization of gastric epithelial
architecture, inflammation and carcinogenesis [44]. Translocation
of O. viverrini ES products such as Ov-GRN-1, into biliary epithelial
cells might likewise interfere with signalling, promoting carcino-
genesis. Moreover, liver fluke ES products inhibit apoptosis
(B. Sripa, unpublished; [45]), further contributing to a tumorigenic
environment.
Despite the deployment of mass drug administration programs
throughout Thailand, opisthorchiasis is still a major public health
concern, and the prevalence of the infection in some areas is
increasing [5,46]. Like other neglected tropical diseases, an
integrated control program is required to have a lasting impact
on reducing transmission and disease burden. To this end, a
vaccine for opisthorchiasis is desperately needed to reduce worm
burdens and minimize pathology. A recombinant vaccine based
on Ov-GRN-1 is particularly attractive because of the potential
role of this protein in establishing a pro-tumorigenic environment
in the bile ducts. Such a vaccine would therefore have a major
impact on reducing both parasite burdens and the incidence of
CCA, the most prevalent and fatal of the liver cancers in north-
east Thailand.
Materials and Methods
Ethics statement
Hamsters used in this study were maintained at the animal
research facility of the Khon Kaen University Faculty of Medicine;
all work was conducted in accordance with protocols approved by
the Khon Kaen University Animal Ethics Committee. Mice used
in this study were housed at the Queensland Institute of Medical
Research (QIMR) animal facility; all work was conducted in
accordance with protocols approved by the QIMR Animal Ethics
Committee.
Preparation of parasite extracts
O. viverrini metacercariae were obtained from naturally infected
cyprinoid fish in Khon Kaen province, Thailand. The fish were
digested with pepsin-HCl, washed and used to infect hamsters
(Mesocricetus auratus) by stomach intubation. Adult O. viverrini worms
were recovered from bile ducts of euthanized hamsters infected for
3 months. Somatic adult worm extract (SAE) was prepared from
frozen and homogenized adult worms resuspended in PBS with a
cocktail of protease inhibitors covering serine, aspartic, cysteine
and metallo-proteases (protease inhibitor cocktail set #5, Roche).
ES products were prepared from live adult worms washed in
antibiotics and incubated in modified RPMI-1640 (Invitrogen) at
37uC/5% CO2. Supernatant containing the ES products was
harvested daily for 7 days [41]. The supernatant was concentrated
20-fold to 100–300 mg/ml with 3 kDa Jumbosep spin concentra-
tors (Pall) and aliquoted for storage at 280uC.
Identification of Ov-GRN-1 in O. viverrini ES products
using LC-MS-MS
Ov-GRN-1 was identified in the ES products of adult O. viverrini
using liquid chromatography tandem mass spectrometry (LC-MS/
MS). The proteins present in ES products were identified by
trypsin digestion followed by a combination of off-gel electropho-
resis and LC-MS/MS as described by us for the analysis of ES
products from the hookworm, Ancylostoma caninum [47]. For
multiple reaction monitoring (MRM), recombinant Ov-GRN-1 in
water and O. viverrini ES were digested as described [47]. A Dionex
3000 HPLC system (Dionex) was used to perform reversed phase
separation of the samples using a C18 300A column
(150 mm62 mm) with a particle size of 5 mm (Phenomenex).
Twenty microliter aliquots of samples were dissolved in 5% formic
acid (aq) and injected onto the HPLC column. The mobile phase
consisted of solvent A (0.1% formic acid (aq)) and solvent B (90/10
acetonitrile/0.1% formic acid (aq)). Tryptic peptides were eluted
using a gradient elution programme of 0–40% B in 40 min, 40–
80% B in 10 min and finally a 5-min hold at 80% B, followed by a
return to 0% B for a 10-min equilibration. The flow rate was
250 ml/min. Eluate from the RP-HPLC column was directly
introduced into the TurboIonSpray source. Mass spectrometry
experiments were performed on a hybrid quadrupole/linear ion
trap 4000 QTRAP MS/MS system (Applied Biosystems). All
analyses were performed using MRM, Information Dependant
Acquisition Initiation Enhanced Product Ion experiments using
both the triple quadrupole and the linear ion trap acquisition
modes. Analyst 1.5.1 software was used for data analysis. The
acquisition protocol to provide mass spectral data for both
identification and characterization involved monitoring the HPLC
eluant using MRM scans; ions over the background threshold of
200 counts per second were subjected to examination using the
enhanced resolution scan to confirm charge states of the multiply
charged molecular ions. The most and next most abundant ions in
each of these scans with a charge state of +2t o+4 or with
unknown charge were subjected to collision induced disassociation
using a rolling collision energy dependent upon the m/z and the
charge state of the ion. An enhanced product ion scan was then
used to acquire the product ion spectrum. The 4000 QTRAP
equipped with a TurboIonSpray Source was operated in the
positive electrospray ionization mode.
Sequence analysis
Sequences were edited and analysed with assistance from the
MacVector software package. Homology searches were performed
using Blast search at NCBI (http://blast.ncbi.nlm.nih.gov/Blast.
cgi). ORFs were analysed for signal peptides/anchors using
SignalP-NN prediction and SignalP-HMM prediction at http://
www.cbs.dtu.dk/services/SignalP/. The O. viverrini cDNA encod-
ing for GRN was termed Ov-grn-1 and was submitted to GenBank
under accession number FJ436341. The structural architecture of
GRN family members was obtained from entry IPR000118 at the
Interpro 18.0 database [48]. Prediction of potential glycosylation
sites was determined using the YingOYang server [49].
Structural modelling
Using version 3 of MODELLER, the three-dimensional
structure of Ov-GRN-1 was predicted based on comparative
modelling to carp granulin [23]. The covalent geometry of the
modelled structure was in agreement with the template structures
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the Ramachandran plot. The quality of the stereo-chemical
structures of the models was determined using PRO-CHECK-
NMR [24]. Pymol was used to view the homology models (http://
www.pymol.org)
Phylogenetic tree
The phylogenetic relationship of Ov-GRN-1 with other GRN
family members was inferred using a neighbor joining analysis in
PAUP beta version 8.0 for Macintosh. Bootstrap values were
determined from 1000 replicates. Where bootstrap values were
below 50%, clades were collapsed to form polytomies. Where
multiple GRN domains were observed within one PGRN protein
(e.g., vertebrates and schistosomes), individual GRN domains
sharing the greatest identity with Ov-GRN-1 were selected and
numbered 1–3 in order of their identities. The individual GRN
domains of human PGRN, however, have been alphabetically
designated A–G in the order GFABCDE, based on their
description in the literature.
RNA extraction and RT-PCR
Extraction of O. viverrini RNA and subsequent reverse
transcription PCR (RT-PCR) was carried out as described [50],
with minor modifications. Total RNA from each developmental
stage of O. viverrini was extracted with Trizol (Invitrogen) according
to the manufacturer’s instructions. Contaminating genomic DNA
was removed by treatment of RNA with DNase I (Promega). For
RT-PCR, first-strand cDNA was synthesized from 1.0 ug of total
RNA using avian myeloblastosis virus reverse transcriptase
(Promega) and an oligo (dT) primer at 42uC for 60 min. A
1.0 ml aliquot of the cDNA was amplified using primers specific for
the control beta-actin mRNA (Forward CGAGGTATCCT-
CACCCTCAA, Reverse GCGACTCGCAACTCATTGTA)
and the target Ov-grn-1 mRNA (Forward CGCGCGCCATGGA-
TACTTTGCAGCCAATT, Reverse GCGCGCCTCGAGTGC-
GACCTTTCGAGCGTT) based on the following conditions:
30 sec denaturation at 94uC, 30 sec annealing at 55uC, and 30 sec
extension at 72uC for 30 cycles. Control RT-PCR reactions were
performed without reverse transcriptase to ensure that amplified
products were derived from cDNA and not contaminating
genomic DNA. PCR products were sized by electrophoresis
through 1% agarose and visualized under UV light after staining
with ethidium bromide.
Recombinant protein expression
Ov-GRN-1 was expressed in both bacterial and insect cell
expression systems. The complete ORF minus the predicted signal
sequence was amplified using Expand polymerase (Roche) from an
adult O. viverrini cDNA library [6] using primers described below
and cloned into the plasmid pMIB/V5-His (Invitrogen) for insect
(Spodoptera frugiperda) cell expression or cloned into the NdeI and
XhoI sites of the pET41a vector (Novagen) for E. coli expression,
thereby removing the GST fusion tag but retaining the 66His tag
and allowing for native N-terminal protein expression. Primers for
insect cell expression were: pMIB F3 HindIII CGCGCGAAGCT-
TAATGGATACTTTGCAGCCAATT; pMIB R3 XbaI GCG-
CGCTCTAGATGCGACCTTTCGAGCGTT. Plasmid prepa-
ration, cell transfection, colony selection and growth of Sf9 cells
(Invitrogen) was as previously described [51]. Primers for E. coli
expression were: pet41 NcoI F7 CGCGCGCCATGGATACTT-
TGCAGCCAATT; pet41 XhoI R7 GCGCGCCTCGAGTGC-
GACCTTTCGAGCGTT. Plasmids were prepared using stan-
dard techniques and used to transform E. coli cell lines (BL21,
rosetta, rosetta-gami cells – Novagen) followed by selection with
kanamycin and other appropriate antibiotics according to the
manufacturer’s instructions. Cells were grown in LB medium at
temperatures between 16–37uC in 1 L Schott bottles at 220 rpm.
Cultures were induced with 1 mM IPTG upon reaching an OD600
of 0.5 and grown overnight before harvesting the cell pellet.
Purification of recombinant proteins
Since both recombinant proteins (derived from E. coli and Sf9
insect cells) contained C-terminal 66His tags, the purification
procedures included immobilized metal ion affinity chromatogra-
phy (IMAC). Purification was undertaken using an AKTA basic
purification system (GE) at 4uC. Henceforth we refer to the E. coli-
derived recombinant protein as Ov-GRN-1e and Sf9-derived
protein as Ov-GRN-1s. For Ov-GRN-1s, 3 L of culture superna-
tant was passed across a 5 ml Hitrap HS HP cation exchange
column (GE) with a gradient of 0–1 M NaCl over 10 column
volumes. Fractions enriched for recombinant protein were
detected using an anti-V5 affinity tag antibody (Invitrogen).
Further purification of these fractions was achieved by a
subsequent IMAC step; protein was bound to 1 ml Ni-NTA resin
(Qiagen) in 10 mM imidazole/sodium phosphate (pH 8) and
washed with 10 column volumes of 20, 40 and 60 mM imidazole,
followed by elution in 250 mM imidazole. Fractions containing
recombinant protein were subjected to a second round of IMAC
as above, followed by concentration to 1 mg/ml and buffer
exchange into PBS using 3 kDa microsep spin columns (Pall). For
purification of Ov-GRN-1e, 3 g of E. coli cell pellet was
resuspended in 30 ml binding buffer (50 mM Tris-HCl,
300 mM NaCl, 0.1% Triton X-100) followed by three disruption
cycles through a chilled French press at 16–18000 psi. The sample
was centrifuged at 4000 g and the pellet was dissolved in 6 M urea
in nickel (Ni)-NTA binding buffer with 40 mM imidazole
overnight at 4uC with gentle mixing. The supernatant was
collected by centrifugation as above and purified by denaturing
IMAC, with 6 M urea in all buffers, over a 5 ml His-trap Ni-IDA
column (GE). The column was washed with 100 mM imidazole
and recombinant protein eluted with 500 mM imidazole/6 M
urea. The eluate was concentrated to 20 mg/ml using 3 kDa
15 ml Amicon Ultra centrifuge concentration devices (Millipore)
and refolded by drop wise addition to a 20-fold greater volume of a
range of refolding buffers [52]. The soluble material was buffer-
exchanged into PBS using a PD10 column (GE).
Antibody production and purification of IgG
Ov-GRN-1e and GRN-1s were adjusted to 0.4 mg/ml and
diluted 1:1 with Freund’s adjuvant and emulsified. Twenty
micrograms of protein (100 ml of protein:adjuvant) was injected
subcutaneously into each of four BALB/c female mice every two
weeks, using Freund’s complete adjuvant for the first immuniza-
tion and Freund’s incomplete adjuvant for the second and third
immunizations. Two weeks after the final immunization, mice
were euthanized, blood collected by cardiac puncture, and sera
recovered from the clotted blood. Control sera were obtained from
mice that were either (1) unimmunized or (2) immunized with an
irrelevant control protein (recombinant Na-GST-1 glutathione-S-
transferase from Necator americanus) [53]. Sera were pooled and
diluted 1:20 with PBS for affinity purification of IgG on Hitrap
protein G (GE) at 4uC using an AKTA basic FPLC. Eluted
fractions were concentrated with 30 kDa nanosep spin concen-
trators (Pall), buffer exchanged into PBS and stored at 280uC.
Western blots
Denaturing and native polyacrylamide gel electrophoresis
(PAGE) was performed using 15% gels. Proteins were electro-
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were then sliced into 3 mm wide strips. Membranes were blocked
in 5% skimmed milk powder (SMP)/PBS with 0.05% Tween 20
(PBST) for 60 min at room temperature (RT) with gentle shaking
and probed overnight with 8 mg/ml mouse IgG diluted in 2%
SMP/PBST at 4uC. Subsequently, membranes were washed
(3610 min each) in PBST at RT followed by probing with horse
radish peroxidase (HRP)-conjugated goat anti-mouse IgG (Zymed
Laboratories) diluted 1:300 in 2% SMP/PBST at RT with gentle
rocking for 60 min. After washing to remove the secondary
antibody, colorimetric signals were developed in the presence of
hydrogen peroxide and diaminobenzidine (DAB) (Pierce).
Immunolocalization
O. viverrini adult worms or liver tissue from hamsters infected
with O. viverrini (weeks 12–16 weeks) were fixed and cut by
microtome into sections of 4 mm [41]. The sections were
deparaffinised in xylene, hydrated in a series of ethanol and
distilled water, respectively. Endogenous peroxidise was eliminated
by incubating sectioned tissues in 5% H2O2 in methanol for
30 min, after which the sections were rehydrated in water and
PBS. Non-specific staining was blocked by incubation in 5%
normal mouse serum in PBS for 30 min. The sections were probed
with pooled mouse purified IgG diluted 1:100–1:500 (v/v) in PBS
and incubated overnight at 4uC. After rinsing 365 min with PBS
the sections were incubated with horseradish peroxidase-conju-
gated goat anti-mouse IgG (Zymed Laboratories) for 1 h. Sections
were rinsed with PBS 2610 min, after which the slides were
developed with DAB. The sections were counterstained with
Mayer’s haematoxylin, dehydrated, cleared in xylene and
mounted in PermountH (Cen-Med). The sections were examined
by light microscopy and images captured with a digital camera.
Reagents for cell proliferation assays
ES products, recombinant proteins and IgG antibodies that
were included in cell culture were filtered under sterile conditions
with 0.22 mM syringe filters (Pall). Dilutions were carried out in
sterile PBS in Twintec 96 well plates (Eppendorf). Samples were
prepared so that 20 ml of ES protein or antibody in sterile PBS was
added to 100 ml of cell culture media. Protein concentrations
described hereafter refer to the final concentration in cell culture
after dilution in media. All assays were conducted either in
triplicate or duplicate, as specified in figure legends. Controls were
relevant for the sample tested: expression matched recombinant
proteins were included to assess effects of recombinant granulin – a
hookworm protein, Na-ASP-2, expressed in insect cells [51] served
as the control protein for Ov-GRN-1s; Sm-TSP-2 EC2 expressed in
E. coli [54] served as the control protein for Ov-GRN-1e.
Antibodies against recombinant proteins for use in cell culture
were purified as above. The Erk1/2 (MAPK) kinase inhibitor,
U0126 (Cell Signalling Technology) was used at a final
concentration of 10 mM in some cell cultures to assess its ability
to block signalling induced by ES products or recombinant Ov-
GRN-1.
Cell proliferation
NIH 3T3 mouse embryonic fibroblast cells (ATCC) were
maintained as specified by ATCC protocols. Briefly, cells were
maintained with regular splitting using 0.25% trypsin every 2–5
days in DMEM (Sigma) with 10% bovine calf serum (BCS) and
16antibiotic/antimycotic (Invitrogen) at 37uC under 5% CO2.T o
assess the effects of ES on cell growth, multiple culture conditions
were investigated in 96 well plates including seed densities (1,000–
10,000 cells/well), cell attachment times before sample addition
(3 h, 6 h, 16 h), BCS concentration (0, 2, 5 and 10%), ES
concentration (10–80 mg/ml) and duration of culture after sample
addition (1–3 days). The ability of live O. viverrini flukes to stimulate
cell proliferation was assessed using a non-contact co-culture
technique as described [4]. KKU-100 is a cell line derived from a
human CCA and was maintained as described [55]. Cell
proliferation was determined using two different approaches.
First, cell numbers were assayed using the WST-1 cell proliferation
reagent (Roche) as per product manual. Briefly the procedure
involves incubating the cells with 10 ul of WST-1 for up to four
hours at 37uC. During this period viable cells, which contain
mitochondrial dehydrogenases, convert WST-1 to a water soluble
formazan dye which has a peak absorbance at 450 nm which is
measured on a Benchmark Plus plate reader (BioRad) and data
were converted into cell numbers per well via comparison to
standard curves.
Cell proliferation was also assessed by counting cell numbers in
real time using a xCELLigence system and E plates (Roche) which
monitors cellular events in real time by measuring electrical
impedance across interdigitated gold micro-electrodes integrated
on the bottom of tissue culture plates. The impedance measure-
ment provides quantitative information about the biological status
of the cells, including cell number, viability, and morphology [27].
Cell culture conditions tested were the same as those tested with
the WST-1 dye (2% BCS, 20 mg/ml ES, 20 mg/ml IgG).
Supporting Information
Figure S1 Reverse transcription PCR of different Opisthorchis life
cycle stages. Lane 1: Egg (snail infective stage), Lane 2:
Metacercariae (mammalian infective stage), Lane 3: Juvenile
(two weeks maturation in liver), Lane 4: Young adult (one month),
Lane 5: Adult (two months). Panel A shows Ov-grn-1 RT-PCR and
panel B shows actin control with equivalent lanes as in panel A.
Negative controls without primers or without reverse transcriptase
showed no bands (not shown).
Found at: doi:10.1371/journal.ppat.1000611.s001 (0.97 MB TIF)
Figure S2 Proliferation of host cells in response to O. viverrini live
worms (A) and ES proteins (B). Data is shown as raw cell numbers
and was used to generate growth ratios shown in Figure 5.
Found at: doi:10.1371/journal.ppat.1000611.s002 (0.56 MB TIF)
Figure S3 O. viverrini ES products induce growth of NIH-3T3
fibroblasts as measured in real time using an xCELLigence system.
The curves represent the differences between each sample and the
cells treated with PBS as measured by Cell Index (xCELLigence
readout); data were normalized prior to sample addition.
Found at: doi:10.1371/journal.ppat.1000611.s003 (0.49 MB TIF)
Figure S4 Recombinant refolded Ov-GRN-1e stimulates growth
of NIH-3T3 fibroblasts at nanomolar concentrations as measured
by the WST-1 assay. Data is shown as raw cell numbers over three
days in the presence of different concentrations of Ov-GRN-1 or
control recombinant protein. Data was used to generate growth
ratios shown in Figure 6.
Found at: doi:10.1371/journal.ppat.1000611.s004 (0.08 MB TIF)
Figure S5 Recombinant refolded Ov-GRN-1e stimulates growth
of NIH-3T3 fibroblasts at nanomolar concentrations as measured
in real time using an xCELLigence system (Roche). Data is shown
as raw cell numbers and was used to generate growth ratios shown
in Figure 7.
Found at: doi:10.1371/journal.ppat.1000611.s005 (0.51 MB TIF)
Figure S6 Inhibition of ES-induced proliferation of NIH-3T3
fibroblasts by anti-Ov-GRN-1 IgG as measured by the WST-1
Liver Fluke Granulin Promotes Host Cell Growth
PLoS Pathogens | www.plospathogens.org 14 October 2009 | Volume 5 | Issue 10 | e1000611assay (A) and in real time using an xCELLigence (B). Data is
shown as raw cell numbers and was used to generate growth ratios
shown in Figure 8.
Found at: doi:10.1371/journal.ppat.1000611.s006 (0.56 MB TIF)
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